Research published in the New England Journal of Medicine finds that the hospital pay-for-performance program adopted in England did not lead to sustained improvement in mortality rates.
The new health insurance exchange policies don’t offer particularly high levels of coverage, as revealed in a report funded by the Robert Wood Johnson Foundation.
Solvadi is the first of a new group of wonder drugs for Hepatitis C, but its cost is staggering. A brief by Milliman examines the impact of the drug on Part D plans.
There is so much talk about patient engagement that it is worth thinking more carefully about what that means and what it really means for costs and quality.
After the first wave of reform law mandated insurance signups, a substantial number of Americans remain uninsured. An Urban Institute brief describes the characteristics of this still-uninsured population.
A study published by the National Bureau of Economic Research finds that, at least in regard to Medicare spending, patient demands are relatively unimportant but physician beliefs about treatment account for a large percent of variation.
The small group insurance market covers about 19 million Americans. A Mark Farrah Associates report describes the current state of the market.
An Agency for Healthcare Research & Quality Statistical Brief gives us data on inpatient hospital costs and utilization from 2003 and 2013 and a projection about the future.
The New England Journal of Medicine carries a thoughtful article on FDA regulation of “mobile health” technologies.
A paper sponsored by the American Federation of Hospitals explores the apparent contrast between falling rates of health spending growth and increased health costs for consumers.